MRK
Merck & Co., Inc. · Healthcare
Exec Chair Kenneth C Frazier sold $87.1M of Merck & Co., Inc.
Sold$87,090,363
$100.44Price
867,084Shares
−55%Stake
What MRK did after the filing
- The stock from Tue, Nov 1 close, $99.76
- +11.8%
- S&P 500, same days
- +3.9%
Measured over 30 trading days, to the Dec 14 close.
Traded Fri, Oct 28. Filed Tue, Nov 1, 12:38 PM ET, during the session. Returns use the Nov 1 close and the Dec 14 close. Not investment advice.